Sundar Selvaraj/NBDF LinkedIn
Sep 26, 2025, 10:44
Sundar Selvaraj – A Scientist Advancing Hemophilia A Research While Living with Severe FXIII Deficiency and VWD 2M
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn:
”Researcher. Advocate. Dad.
Sundar Selvaraj brings a unique dual perspective to the LEE Research Advisory Council, as a scientist studying hemophilia A and as someone living with both severe factor XIII deficiency and type 2M von Willebrand disease.
Based in Michigan, he’s committed to advancing biomedical research while ensuring patient voices stay at the center.
Learn more about Sundar.”
More winner stories featured in Hemostasis Today.
-
Sep 14, 2026, 16:14Susanne Lager: Isthmin-2 Emerges as an Early Predictor of Pregnancy Complications
-
Sep 14, 2026, 15:53Leonard Valentino: Advancing a New Model of Patient-Led Research
-
Sep 14, 2026, 15:48Adishwar Rao: LAAC vs Oral Anticoagulation in Atrial Fibrillation
-
Sep 14, 2026, 15:36Lesley Van Wyk: Hemolytic Anemia Quick Revision – Tips and Tricks
-
Sep 14, 2026, 15:35Maha Othman: ISTH-BAT Reference Ranges Validated Across Five Continents in Children
-
Sep 14, 2026, 15:30Umberto Pensato։ Left Ventricular Dysfunction and DOAC Benefit in ESUS
-
Sep 14, 2026, 15:22Meral Kayikcioglu: Why Do Women and Men Differ in LDL-C Management?
-
Sep 14, 2026, 15:22James Crowley: The Complex Role of CRP in Cardiovascular Risk and Atherosclerosis
-
Sep 14, 2026, 15:16Factor XIII Deficiency An Often-Missed Bleeding Disorder